Embecta (EMBC) Revenue & Revenue Breakdown
Embecta Revenue Highlights
Latest Revenue (Y)
$1.08B
Latest Revenue (Q)
$259.00M
Main Segment (Y)
Safety
Main Geography (Y)
UNITED STATES
Embecta Revenue by Period
Embecta Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $1.08B | -3.80% |
| 2024-09-30 | $1.12B | 0.21% |
| 2023-09-30 | $1.12B | -0.77% |
| 2022-09-30 | $1.13B | -3.05% |
| 2021-09-30 | $1.17B | 7.32% |
| 2020-09-30 | $1.09B | -2.12% |
| 2019-09-30 | $1.11B | - |
Embecta generated $1.08B in revenue during NA 2025, up -3.80% compared to the previous quarter, and up 99.53% compared to the same period a year ago.
Embecta Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $259.00M | -1.11% |
| 2024-12-31 | $261.90M | -8.46% |
| 2024-09-30 | $286.10M | 4.99% |
| 2024-06-30 | $272.50M | -5.12% |
| 2024-03-31 | $287.20M | 3.57% |
| 2023-12-31 | $277.30M | -1.63% |
| 2023-09-30 | $281.90M | -1.47% |
| 2023-06-30 | $286.10M | 3.25% |
| 2023-03-31 | $277.10M | 0.51% |
| 2022-12-31 | $275.70M | 0.40% |
| 2022-09-30 | $274.60M | -5.67% |
| 2022-06-30 | $291.10M | 6.05% |
| 2022-03-31 | $274.50M | -5.12% |
| 2021-12-31 | $289.30M | -3.73% |
| 2021-09-30 | $300.50M | 1.86% |
| 2021-06-30 | $295.00M | 3.80% |
| 2021-03-31 | $284.20M | -0.39% |
| 2020-12-31 | $285.30M | 51.11% |
| 1968-12-31 | $188.80M | - |
Embecta generated $259.00M in revenue during Q2 2025, up -1.11% compared to the previous quarter, and up 93.40% compared to the same period a year ago.
Embecta Revenue Breakdown
Embecta Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Sep 25 | Sep 24 |
|---|---|---|
| Product and Service, Other | $14.00M | $10.30M |
| Safety | $137.80M | $129.40M |
| Manufacturing Facility | $19.90M | $12.80M |
Embecta's latest annual revenue breakdown by segment (product or service), as of Sep 25: Safety (80.26%), Manufacturing Facility (11.59%), and Product and Service, Other (8.15%).
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 | Mar 25 |
|---|---|---|---|
| Safety | $68.80M | $34.80M | $34.20M |
| Manufacturing Facility | $10.00M | $5.50M | $4.40M |
| Product and Service, Other | $7.50M | $3.20M | $3.30M |
Embecta's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: Safety (79.72%), Manufacturing Facility (11.59%), and Product and Service, Other (8.69%).
Embecta Revenue Breakdown by Country
Annual Revenue by Country
| Country | Sep 25 | Sep 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|
| UNITED STATES | $579.10M | $607.20M | $601.40M | $600.30M |
| Non-US | $501.30M | $515.90M | $519.40M | $529.20M |
Embecta's latest annual revenue breakdown by geography, as of Sep 25: UNITED STATES (53.60%), and Non-US (46.40%).
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 | Mar 25 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US | $242.20M | $135.30M | $123.80M | $247.60M | $139.60M | $128.70M | $130.10M | $132.20M | $130.70M | $126.40M | $124.70M | $133.10M | $134.70M | $138.40M |
| UNITED STATES | $283.70M | $160.20M | $135.20M | $311.00M | $147.60M | $148.60M | $151.80M | $153.90M | $146.40M | $149.30M | $149.90M | $158.00M | $139.80M | - |
| United States of America, Dollars | - | - | - | - | - | - | - | - | - | - | - | - | - | $150.90M |
Embecta's latest quarterly revenue breakdown by geography, as of Sep 25: UNITED STATES (53.95%), and Non-US (46.05%).
Embecta Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| EVH | Evolent Health | $2.55B | - |
| EMBC | Embecta | $1.08B | $259.00M |
| EBS | Emergent BioSolutions | $1.04B | $231.10M |
| MYGN | Myriad Genetics | $753.20M | $213.10M |
| CDNA | CareDx | $333.79M | $100.06M |
| MRVI | Maravai LifeSciences | $259.19M | $41.63M |
| SIGA | SIGA | $138.72M | $2.62M |
| VIR | Vir Bio | $74.20M | $240.00K |
| AQST | Aquestive Therapeutics | $57.56M | $10.00M |
| PRME | Prime Medicine | $2.98M | $1.23M |
| PSNL | Personalis | - | - |